Literature DB >> 34318925

Advancing Precision Medicine Through the New Pharmacogenomics Global Research Network.

Kathleen M Giacomini1, Jason H Karnes2, Kristine R Crews3, Andrew A Monte4, William A Murphy5, Akinyemi Oni-Orisan6, Laura B Ramsey7,8,9, Jun J Yang3, Michelle Whirl-Carrillo10.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34318925      PMCID： PMC8881968          DOI： 10.1002/cpt.2340

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Embracing Genetic Diversity to Improve Black Health.

Authors:  Akinyemi Oni-Orisan; Yusuph Mavura; Yambazi Banda; Timothy A Thornton; Ronnie Sebro
Journal:  N Engl J Med       Date:  2021-02-10       Impact factor: 91.245

2.  Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.

Authors:  Meghan J Chenoweth; Kathleen M Giacomini; Munir Pirmohamed; Susan L Hill; Ron H N van Schaik; Matthias Schwab; Alan R Shuldiner; Mary V Relling; Rachel F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2019-11-06       Impact factor: 6.875

3.  Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.

Authors:  Jun J Yang; Wendy Landier; Wenjian Yang; Chengcheng Liu; Lindsey Hageman; Cheng Cheng; Deqing Pei; Yanjun Chen; Kristine R Crews; Nancy Kornegay; F Lennie Wong; William E Evans; Ching-Hon Pui; Smita Bhatia; Mary V Relling
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

Review 4.  The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later.

Authors:  Mary V Relling; Teri E Klein; Roseann S Gammal; Michelle Whirl-Carrillo; James M Hoffman; Kelly E Caudle
Journal:  Clin Pharmacol Ther       Date:  2019-11-05       Impact factor: 6.875

5.  Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.

Authors:  David J Milan; Albert M Kim; Jeffrey R Winterfield; Ian L Jones; Arne Pfeufer; Serena Sanna; Dan E Arking; Adam H Amsterdam; Khaled M Sabeh; John D Mably; David S Rosenbaum; Randall T Peterson; Aravinda Chakravarti; Stefan Kääb; Dan M Roden; Calum A MacRae
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

6.  PharmVar and the Landscape of Pharmacogenetic Resources.

Authors:  Andrea Gaedigk; Michelle Whirl-Carrillo; Victoria M Pratt; Neil A Miller; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-11-23       Impact factor: 6.875

7.  African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa.

Authors:  Collet Dandara; Collen Masimirembwa; Yosr Z Haffani; Bernhards Ogutu; Jenniffer Mabuka; Eleni Aklillu; Oluseye Bolaji
Journal:  AAS Open Res       Date:  2019-06-04

8.  Pharmacogenomics Clinical Annotation Tool (PharmCAT).

Authors:  Katrin Sangkuhl; Michelle Whirl-Carrillo; Ryan M Whaley; Mark Woon; Adam Lavertu; Russ B Altman; Lester Carter; Anurag Verma; Marylyn D Ritchie; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-09-17       Impact factor: 6.875

9.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245

10.  PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.

Authors:  Rachel Huddart; Michelle Whirl-Carrillo; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2020-10-24       Impact factor: 6.903
  10 in total
  4 in total

1.  Pharmacogenomics in cancer supportive care: key issues and future directions.

Authors:  Jai N Patel; Ian Olver; Fred Ashbury
Journal:  Support Care Cancer       Date:  2021-08-01       Impact factor: 3.603

Review 2.  Opioids and Falls Risk in Older Adults: A Narrative Review.

Authors:  Roosa-Emilia Virnes; Miia Tiihonen; Niina Karttunen; Eveline P van Poelgeest; Natalie van der Velde; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2022-03-15       Impact factor: 3.923

3.  Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.

Authors:  P García-Alfonso; M Saiz-Rodríguez; R Mondéjar; J Salazar; D Páez; A M Borobia; M J Safont; I García-García; R Colomer; X García-González; M J Herrero; L A López-Fernández; F Abad-Santos
Journal:  Clin Transl Oncol       Date:  2021-11-13       Impact factor: 3.405

Review 4.  Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.

Authors:  Sonya C Tang Girdwood; Katelyn M Rossow; Sara L Van Driest; Laura B Ramsey
Journal:  Pediatr Res       Date:  2021-04-06       Impact factor: 3.756
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.